3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
375
Neoplasms
324
Neoplasm Metastasis
288
Leukemia, Myeloid, Acute
282
Breast Neoplasms
273
Colorectal Neoplasms
238
Melanoma
196
Ovarian Neoplasms
191
Recurrence
187
Multiple Myeloma
180
Prostatic Neoplasms
156
Lung Neoplasms
156
Pancreatic Neoplasms
153
Squamous Cell Carcinoma of Head and Neck
150
Lymphoma, Non-Hodgkin
146
Glioblastoma
145
Triple Negative Breast Neoplasms
120
Myelodysplastic Syndromes
117
Carcinoma, Renal Cell
111
Stomach Neoplasms
110
Glioma
108
Advanced Solid Tumors
108
Brain Neoplasms
105
Precursor Cell Lymphoblastic Leukemia-Lymphoma
104
Lymphoma
103
Lymphoma, Large B-Cell, Diffuse
102
Lymphoma, B-Cell
98
Carcinoma, Hepatocellular
95
Endometrial Neoplasms
92
Lymphoma, Follicular
91
Interventions
Granulocyte-Macrophage Colony-Stimulating Factor
1
Diphtheria-Tetanus Vaccine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Xanthomatosis, Cerebrotendinous
×
1 year
×
Clear all
NCT03396575
2025-10-29
BRAVO
University of Florida
Phase 1
Terminated
11 enrolled